MiNK Therapeutics, Inc. (INKT) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$12.64M | -12.0% |
| 2024 | -$11.29M | +50.8% |
| 2023 | -$22.92M | +25.9% |
| 2022 | -$30.95M | -9.1% |
| 2021 | -$28.36M | -93.7% |
| 2020 | -$14.64M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$12.64M | -12.0% |
| 2024 | -$11.29M | +50.8% |
| 2023 | -$22.92M | +25.9% |
| 2022 | -$30.95M | -9.1% |
| 2021 | -$28.36M | -93.7% |
| 2020 | -$14.64M | — |